| pubmed-article:8868285 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8868285 | lifeskim:mentions | umls-concept:C0020538 | lld:lifeskim |
| pubmed-article:8868285 | lifeskim:mentions | umls-concept:C0003009 | lld:lifeskim |
| pubmed-article:8868285 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:8868285 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8868285 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:8868285 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:8868285 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8868285 | pubmed:dateCreated | 1997-1-30 | lld:pubmed |
| pubmed-article:8868285 | pubmed:abstractText | We investigated whether induced hypertension could enhance tumor uptake of monoclonal antibody. 111In-DTPA-A7 (IgG1 against 40kD tumor associated glycoprotein) was injected into colon carcinoma xenografted mice which were subcutaneously implanted with micro-osmotic pump containing angiotensin II (AT-II). Biodistribution was observed in groups of mice infused with AT-II at rate of 0.5 micrograms/kg/min (L) or 1 microgram/kg/min (H) and compared with a group of mice infused with saline (S). Tumor uptake of 111In-A7 in L and H was 1.32 and 1.57 times greater than S at 48 h after intravenous injection of A7. Normal organ uptakes also tended to be increased by AT-II infusion. Further study is needed to get optimum effect of hypertensive treatment on biodistribution of radiolabeled MoAb. | lld:pubmed |
| pubmed-article:8868285 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8868285 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8868285 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8868285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8868285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8868285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8868285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8868285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8868285 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8868285 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8868285 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:8868285 | pubmed:issn | 0969-8051 | lld:pubmed |
| pubmed-article:8868285 | pubmed:author | pubmed-author:KonishiSS | lld:pubmed |
| pubmed-article:8868285 | pubmed:author | pubmed-author:HisadaKK | lld:pubmed |
| pubmed-article:8868285 | pubmed:author | pubmed-author:TonamiNN | lld:pubmed |
| pubmed-article:8868285 | pubmed:author | pubmed-author:YokoyamaKK | lld:pubmed |
| pubmed-article:8868285 | pubmed:author | pubmed-author:KinuyaSS | lld:pubmed |
| pubmed-article:8868285 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8868285 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:8868285 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8868285 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8868285 | pubmed:pagination | 137-40 | lld:pubmed |
| pubmed-article:8868285 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:meshHeading | pubmed-meshheading:8868285-... | lld:pubmed |
| pubmed-article:8868285 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8868285 | pubmed:articleTitle | Effect of induced hypertension with angiotensin II infusion on biodistribution of 111in-labeled monoclonal antibody. | lld:pubmed |
| pubmed-article:8868285 | pubmed:affiliation | Department of Nuclear Medicine, Kanazawa University School of Medicine, Ishikawa, Japan. | lld:pubmed |
| pubmed-article:8868285 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8868285 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8868285 | lld:pubmed |
